PMC:7396557 / 1792-2054
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T19 | 7-13 | UBERON:0002405 | denotes | immune |
| T20 | 14-24 | GO:0065007 | denotes | regulation |
| T21 | 45-54 | UBERON:0002048 | denotes | pulmonary |
| T22 | 202-210 | SP_7 | denotes | COVID-19 |
| T67341 | 7-13 | UBERON:0002405 | denotes | immune |
| T37032 | 14-24 | GO:0065007 | denotes | regulation |
| T39065 | 45-54 | UBERON:0002048 | denotes | pulmonary |
| T4364 | 202-210 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T13 | 202-210 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T58292 | 14-24 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 65-247 | Sentence | denotes | In addition, clinical research results and Chinese treatment data showed that the CPMs had good therapeutic efficacy in the treatment of COVID-19, and adverse reactions were minimal. |
| T16 | 249-260 | Sentence | denotes | Conclusions |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T2 | 0-5 | Phenotype | denotes | shock | http://purl.obolibrary.org/obo/HP_0031273 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 24 | 0-5 | Disease | denotes | shock | MESH:D012769 |
| 25 | 202-210 | Disease | denotes | COVID-19 | MESH:C000657245 |